Clinical trial on efficacy of eradication therapy for Helicobacter pylori infection to improve gastric atrophy.

Clinical trial on efficacy of eradication therapy for Helicobacter pylori infection to improve gastric atrophy. - Helicobacter eradication for gastric atrophy improvement.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001938

Enrollment

150

Registered

2009-05-02

Start date

2009-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients of atrophic gastritis with H. pylori infection

Interventions

Eradication therapy for Helicobacter pylori infection

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. positive for H. pylroi infection 2. atrophic gastritis by endoscopy

Exclusion criteria

Exclusion criteria: 1. gastric malignancies or gastric adenomas 2. gastroduodenal ulcers 3. allergy for medicine used in this study

Design outcomes

Primary

Measure	Time frame
pathological examination of gastric atrophy	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026